Guy Jerusalem, Professor at University of Liege, shared on LinkedIn:
“Are you working in the field of breast cancer? Are you interested in writing a manuscript on systemic therapy escalation or de-escalation?
Prof Mario Campone, Prof Antonio Llombart-Cussac and myself are guest editors of a research topic in this field.
Review articles and original research articles are eligible for publication.
Manuscripts about biomarkers guiding treatment strategies are also of major interest.
New recent standards and perspectives which need further validation are within the scope of this topic.
Further informations are available directly at the website of Frontiers in Oncology:
The deadline for full manscript submission is APR 30, 2027 but please indicate us ASAP if you are interested to contribute a manuscript including a short summary of the content.
Peer-review is initiated when we receive a full manuscript. If your manuscript is accepted for publication, this will be done rapidly without waiting for the final deadline.
Breast cancer de-escalation strategies biomarkers.”
You can also read: Breast Cancer Highlights From ASCO 2026: ADCs, Biomarkers, and Earlier Treatment Strategies Take Center Stage
